|
End-of-day quote
Canadian Securities Exchange
2026-10-02
|
5-day change | 1st Jan Change | ||
| 0.0300 CAD | 0.00% |
|
-14.29% | -60.00% |
| Market Cap | 3.92M 2.75M 2.44M 2.28M 2.08M 264M 3.96M 27.61M 10.7M 135M 10.33M 10.11M 434M | P/E 2024 |
-1.85x | P/E 2025 | -3.69x |
|---|---|---|---|---|---|
| Enterprise Value | 5.43M 3.81M 3.38M 3.16M 2.88M 366M 5.48M 38.21M 14.81M 187M 14.29M 13.98M 600M | EV / Sales 2024 |
0.67x | EV / Sales 2025 | 0.89x |
| Free-Float |
82.94% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| HERB | End-of-day quote | |
Canadian Securities Exchange
| HERB | Delayed | |
|
OTC Markets
| LUFFF | Delayed | |
|
Deutsche Boerse AG
| HA9 | Delayed |
| 1 week | -14.29% | ||
| Current month | +20.00% | ||
| 3 months | -40.00% | ||
| 6 months | -33.33% | ||
| Current year | -60.00% |
| 1 week | 0.02 |  | 0.04 |
| 1 month | 0.02 | | 0.04 |
| Current year | 0.02 | | 0.12 |
| 1 year | 0.02 | | 0.13 |
| 3 years | 0.02 | | 0.13 |
| 5 years | 0.02 | | 0.25 |
| 10 years | 0.02 | | 9.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Philip Campbell
CEO | Chief Executive Officer | - | 2020-05-14 |
Jason Vandenberg
DFI | Director of Finance/CFO | 49 | 2022-01-17 |
Aron Tegenfeldt
PRN | Corporate Officer/Principal | - | 2022-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Philip Campbell
BRD | Director/Board Member | - | 2020-05-14 |
Drew Malcolm
BRD | Director/Board Member | - | 2020-06-23 |
Herb Dhaliwal
CHM | Chairman | 73 | 2026-04-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/23/26 | Buy | Chairman | 200,000 | 0.1558% | ||
| 9/14/26 | Buy | Chairman | 100,000 | 0.0779% | ||
| 9/2/26 | Buy | Chairman | 100,000 | 0.0779% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -14.29% | -62.50% | -70.00% | 2.75M | |
| +0.21% | -3.61% | +35.14% | +110.90% | 1,019B | |
| -0.93% | -6.83% | +34.66% | +61.24% | 617B | |
| -0.33% | -1.65% | +13.77% | +77.61% | 464B | |
| -3.41% | -6.13% | +57.17% | +34.72% | 356B | |
| +0.56% | -2.28% | +20.42% | +40.78% | 333B | |
| -0.08% | -4.27% | +9.85% | +33.23% | 267B | |
| -0.99% | -5.97% | -7.70% | +7.74% | 244B | |
| -0.91% | -4.43% | +35.87% | +50.75% | 218B | |
| -0.78% | -5.57% | +26.55% | +92.42% | 179B | |
| Average | -0.68% | -4.62% | +16.32% | +43.94% | 369.72B | |
| Weighted average by Cap. | -0.62% | -3.54% | +28.15% | +67.93% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.92M 6.96M 6.19M 5.77M 5.26M 669M 10.02M 69.86M 27.07M 342M 26.14M 25.57M 1.1B | 12.12M 8.5M 7.56M 7.05M 6.43M 818M 12.24M 85.35M 33.07M 418M 31.93M 31.24M 1.34B |
| Net income | -2.77M -1.95M -1.73M -1.61M -1.47M -187M -2.8M -19.52M -7.56M -95.6M -7.3M -7.14M -307M | -1.84M -1.29M -1.15M -1.07M -976K -124M -1.86M -12.96M -5.02M -63.48M -4.85M -4.74M -204M |
| Net Debt | 1.37M 964K 857K 800K 729K 92.72M 1.39M 9.68M 3.75M 47.4M 3.62M 3.54M 152M | 1.51M 1.06M 938K 876K 798K 102M 1.52M 10.6M 4.11M 51.9M 3.97M 3.88M 167M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | $0.0300 | 0.00% | 21,000 |
| 26-10-01 | $0.0300 | +20.00% | 74,197 |
| 26-09-30 | $0.0250 | -28.57% | 168,038 |
| 26-09-29 | $0.0350 | 0.00% | 28,857 |
| 26-09-28 | $0.0350 | 0.00% | 6,500 |
- Stock Market
- Stocks
- HERB Stock
Select your edition
All financial news and data tailored to specific country editions
